Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Pharm Sci. 2020 Jul 20;109(10):3095–3104. doi: 10.1016/j.xphs.2020.07.013

Table 2.

Percent of Fentanyl Remaining in TDS After Skin Permeation Experiments and Percent Recovery in the Experiments.

Percent Remaining in TDS After Each Protocola Percent Recoveryb
1 2 3 4 5 6 7 8 Average, All Protocols
no Heat 11–12 h 18–19 h 6–72 h 24–72 h 48–72 h multiple Heat 0–72 h
TDS-Z 66 ± 10 98 ± 5 94 ± 3 48 ± 7 60 ± 4 61 ± 8 58 ± 4 58 ± 10 110 ± 2
TDS-V 52 ± 5 76 ± 3 74 ± 3 35 ± 5 35 ± 8 37 ± 7 35 ± 6 32 ± 7 95 ± 1
TDS-M 46 ± 9 87 ± 6 91 ± 2 22 ± 6 16 ± 10 26 ± 14 27 ± 10 26 ± 8 105 ± 2
a

Mean ± SEM, n = 4 skin donors (3–4 skin replicates for each skin donor).

b

Mean ± SEM, n = 8 protocols. Percent recovery was based on total drug content in the TDS according to the drug product labels. Percent recovery does not include fentanyl in skin; the amounts of fentanyl remaining in the skin were assumed to be small at the end of the experiments and were not determined during the extraction analysis.